| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |